Refine
Has Fulltext
- no (39) (remove)
Year of publication
- 2014 (39) (remove)
Document Type
- Article (21)
- Conference Proceeding (16)
- Preprint (1)
- Review (1)
Is part of the Bibliography
- yes (39)
Keywords
- cardiopulmonary exercise testing (2)
- hypertension (2)
- Aging (1)
- Bimanual probe (1)
- Biochemical profiles (1)
- DDP-4 inhibition (1)
- Doping tests (1)
- Dual-task walking (1)
- ECG (1)
- Error monitoring (1)
- Executive function (1)
- First psychotic episode (1)
- Fist-Edge-Palm test (1)
- Focus group (1)
- GLP-1 receptor (1)
- Germany (1)
- Locomotion (1)
- Luria (1)
- Maturation (1)
- Maximal oxygen uptake (1)
- Motor performance (1)
- Movement (1)
- National Socialism (1)
- Neural activation (1)
- Physical fitness (1)
- Primary school (1)
- Psychology (1)
- Resistance training (1)
- Schizophrenia (1)
- Schizophrenia spectrum disorders (1)
- Schutzstaffel (SS, Protection Squadron) (1)
- Steroid use (1)
- Trunk muscle strength (1)
- VO2mdx (1)
- Youth (1)
- adolescents (1)
- affect misattribution procedure (1)
- cardiovascular diseases (1)
- central administration (1)
- consecutive tests (1)
- core (1)
- coronary artery disease (1)
- cost and cost analysis (1)
- cost-benefit analysis (1)
- diabetes (1)
- diabetic nephropathy (1)
- drug monitoring (1)
- echocardiography (1)
- electromyography (1)
- elite sports (1)
- exercise (1)
- exercise capacity (1)
- exhaustion (1)
- explosive force production (1)
- fNIRS (1)
- fatigue (1)
- gastrocnemius muscle (1)
- health (1)
- health status (1)
- incretins (1)
- inpatient cardiac rehabilitation (1)
- inter-rater variability (1)
- isokinetic (1)
- kardiologische Rehabilitation (1)
- kidney (1)
- koronare Herzkrankheit (1)
- korperliche Leistungsfahigkeit (1)
- lactate threshold (1)
- laterality (1)
- maximal isometric contraction (1)
- medication adherence (1)
- metabolic device (1)
- ministers and civil servants (1)
- mirror (1)
- muscle architecture (1)
- musculoskeletal ultrasound (1)
- paediatric athlete (1)
- performance diagnostics (1)
- political advisers (1)
- political responsiveness (1)
- politicization (1)
- pre-participation screening (1)
- prevention (1)
- probability (1)
- public administration (1)
- renal impairment (1)
- risk assessment (1)
- sensorimotor cortex (1)
- sickness absence (1)
- sonography (1)
- sport and race (1)
- strength performance (1)
- stroke (1)
- study design (1)
- sudden cardiac death (1)
- team training (1)
- test-retest reliability (1)
Institute
- Department Sport- und Gesundheitswissenschaften (39) (remove)
Flexion-extension ratio of trunk peak torque measures and antagonistic activity in males and females
(2014)
Purpose of reviewIncretin-based therapy with glucagon-like peptide-1 receptor (GLP-1R) agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors is considered a promising therapeutic option for type 2 diabetes mellitus. Cumulative evidence, mainly from preclinical animal studies, reveals that incretin-based therapies also may elicit beneficial effects on kidney function. This review gives an overview of the physiology, pathophysiology, and pharmacology of the renal incretin system.Recent findingsActivation of GLP-1R in the kidney leads to diuretic and natriuretic effects, possibly through direct actions on renal tubular cells and sodium transporters. Moreover, there is evidence that incretin-based therapy reduces albuminuria, glomerulosclerosis, oxidative stress, and fibrosis in the kidney, partially through GLP-1R-independent pathways. Molecular mechanisms by which incretins exert their renal effects are understood incompletely, thus further studies are needed.SummaryThe GLP-1R and DPP-4 are expressed in the kidney in various species. The kidney plays an important role in the excretion of incretin metabolites and most GLP-1R agonists and DPP-4 inhibitors, thus special attention is required when applying incretin-based therapy in renal impairment. Preclinical observations suggest direct renoprotective effects of incretin-based therapies in the setting of hypertension and other disorders of sodium retention, as well as in diabetic and nondiabetic nephropathy. Clinical studies are needed in order to confirm translational relevance from preclinical findings for treatment options of renal diseases.
We sought to investigate the effects of wearing a mobile respiratory gas analysis system during a treadmill test on blood lactate (bLa) concentrations and commonly applied bLa thresholds. A total of 16 recreational athletes (31 +/- 3 years, V0205: 58 6 ml min(-1)-kg(-1)) performed one multistage treadmill test with and one without gas exchange measurements (GEM and noGEM). The whole bLa curve, the lactate threshold (LT), the individual anaerobic thresholds according to Stegmann(IAT(sr)) and Dickhuth (IAT(Di)), and a fixed bLa concentration of 4 mmob.l(-1) (OBLA) were evaluated. The bLa curve was shifted slightly leftward in GEM compared to noGEM (P<0.05), whereas the heart rate response was not different between conditions (P= 0.89). There was no difference between GEM and noGEM for LT (2.61 +/- 0.34 vs. 2.64 +/- 0.39 m(-1) s(-1) P=0.49) and IAT(st) (3.47 +/- 0.42 vs. 3.55 +/- 0.47m-s(-1), P=0.12). However, IATD(Di) (3.57 +/- 0.39 vs. 3.66 +/- 0.44m-s(-1), P<0.01) and OBLA (3.85 +/- 0.46 vs. 3.96 +/- 0.47m-s-1, P<0.01) occurred at slower running velocities in GEM. The bLa response to treadmill tests is mildly affected by wearing a mobile gas analysis system. This also applies to bLa thresholds located at higher exercise intensities. While the magnitude of the effects is of little importance for recreational athletes, it might be relevant for elite athletes and scientific studies.
Changes in performance parameters over four consecutive maximal incremental cycling tests were investigated to determine how many tests can be performed within one single day without negatively affecting performance. Sixteen male and female subjects (eight trained (T): 25 +/- 3 yr, BMI 22.6 +/- 2.5 kg center dot m(-2), maximal power output (P-max) 4.6 +/- 0.5 W center dot kg(-1); eight untrained (UT): 27 +/- 3 yr, BMI 22.3 +/- 1.2 kg center dot m(-2), P-max 2.9 +/- 0.3 W center dot kg(-1)) performed four successive maximal incremental cycling tests separated by 1.5 h of passive rest. Individual energy requirements were covered by standardised meals between trials. Maximal oxygen uptake (VO2max) remained unchanged over the four tests in both groups (P = 0.20 and P = 0.33, respectively). P-max did not change in the T group (P = 0.32), but decreased from the third test in the UT group (P < 0.01). Heart rate responses to submaximal exercise were elevated from the third test in the T group and from the second test in the UT group (P < 0.05). The increase in blood lactate shifted rightward over the four tests in both groups (P < 0.001 and P < 0.01, respectively). Exercise-induced net increases in epinephrine and norepinephrine were not different between the tests in either group (P 0.15). If VO2max is the main parameter of interest, trained and untrained individuals can perform at least four maximal incremental cycling tests per day. However, because other parameters changed after the first and second test, respectively, no more than one test per day should be performed if parameters other than VO2max are the prime focus.